Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

RPR-238677 identified as a potent, orally available p38 MAP kinase inhibitor

May 24, 2002

Novel MMP inhibitors identified by Pfizer research group

May 23, 2002

Novartis launches TARGET trial of Prexige in arthritis

May 22, 2002

Update on status of T-614, a new antiarthritic drug

May 17, 2002

Edema and loss of blood pressure control in elderly hypertensive patients given COX-2 inhibitors

May 16, 2002

Potent and selective alpha4 integrin inhibitors useful for inflammatory conditions

May 10, 2002

Cathepsin inhibitors and potential therapeutic uses described by Boehringer Ingelheim

May 8, 2002

BIRB-796BS: structure, pharmacological activity described at recent meeting

May 8, 2002

Ketoprofen amides with selective activity against COX-2

May 8, 2002

Antiinflammatory and cytoprotective properties of statins

May 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...